Status:
COMPLETED
Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer
Detailed Description
Patients with serious cancers, like advanced lung cancer, often experience physical symptoms, such as pain or shortness of breath. In addition, both patients and their loved ones (family and friends) ...
Eligibility Criteria
Inclusion
- Diagnosed with advanced non-small cell lung cancer, small cell lung cancer, or mesothelioma, being treated with non-curative intent, and informed of advanced disease within the prior twelve weeks
- Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 2 (symptomatic and in bed \<50% of the day)
- The ability to read and respond to questions in English or Spanish
- Primary cancer care at one of the three participating sites
- Age \> 18 years
Exclusion
- Already receiving outpatient PC or hospice services
- Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
507 Patients enrolled
Trial Details
Trial ID
NCT03337399
Start Date
February 1 2018
End Date
December 31 2023
Last Update
May 15 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
2
Duke University
Durham, North Carolina, United States, 27710
3
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104